{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:42:23Z","timestamp":1784601743919,"version":"3.55.0"},"reference-count":211,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lodz","award":["503\/3-011-02\/503-31-002"],"award-info":[{"award-number":["503\/3-011-02\/503-31-002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: While the prevalence of heart failure with preserved ejection fraction (HFpEF) has increased over the last two decades, there still remains a lack of effective treatment. A key therapeutic challenge is posed by the absence of animal models that accurately replicate the complexities of HFpEF. The present review summarizes the effects of a wide spectrum of therapeutic agents on HF. Methods: Two online databases were searched for studies; in total, 194 experimental protocols were analyzed following the PRISMA protocol. Results: A diverse range of models has been proposed for studying therapeutic interventions for HFpEF, with most being based on pressure overload and systemic hypertension. They have been used to evaluate more than 150 different substances including ARNIs, ARBs, HMGR inhibitors, SGLT-2 inhibitors and incretins. Existing preclinical studies have primarily focused on LV diastolic performance, and this has been significantly improved by a wide spectrum of candidate therapeutic agents. Few experiments have investigated the normalization of pulmonary congestion, exercise capacity, animal mortality, or certain molecular hallmarks of heart disease. Conclusions: The development of comprehensive preclinical HFpEF models, with multi-organ system phenotyping and physiologic stress-based functional testing, is needed for more successful translation of preclinical research to clinical trials.<\/jats:p>","DOI":"10.3390\/ph16101449","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T07:28:44Z","timestamp":1697095724000},"page":"1449","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-0733","authenticated-orcid":false,"given":"Magdalena","family":"Jasi\u0144ska-Stroschein","sequence":"first","affiliation":[{"name":"Department of Biopharmacy, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: The prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review","volume":"18","author":"Hoes","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pcad.2020.04.011","article-title":"Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence","volume":"63","author":"Iannaccone","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11","author":"Borlaug","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12471-016-0815-9","article-title":"Animal models of heart failure with preserved ejection fraction","volume":"24","author":"Heinonen","year":"2016","journal-title":"Neth. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine Models of Heart Failure with Preserved Ejection Fraction: A \u201cFishing Expedition\u201d","volume":"2","author":"Backman","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jasi\u0144ska-Stroschein, M. (2022). Searching for an experimental rodent model of heart failure with preserved ejection fraction: Revisited. Biomed. Pharmacother., 152.","DOI":"10.1016\/j.biopha.2022.113251"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"H1670","DOI":"10.1152\/ajpheart.00024.2018","article-title":"Targeted HFpEF therapy based on matchmaking of human and animal models","volume":"315","author":"Schroen","year":"2018","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"eabd7064","DOI":"10.1126\/scitranslmed.abd7064","article-title":"Nicotinamide for the treatment of heart failure with preserved ejection fraction","volume":"13","author":"Abdellatif","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/dom.13536","article-title":"Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized 13 C magnetic resonance spectroscopy study","volume":"21","author":"Abdurrachim","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jcsm.12968","article-title":"Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility","volume":"13","author":"Adams","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/HJH.0000000000000184","article-title":"Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats","volume":"32","author":"Akahori","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Akinwumi, B.C., Raj, P., Lee, D.I., Acosta, C., Yu, L., Thomas, S.M., Nagabhushanam, K., Majeed, M., Davies, N.M., and Netticadan, T. (2017). Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat. Molecules, 22.","DOI":"10.3390\/molecules22020204"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.120.14704","article-title":"Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage","volume":"75","author":"Altara","year":"2020","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-021-01270-1","article-title":"Sacubitril\/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness","volume":"20","author":"Aroor","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13553","DOI":"10.1038\/s41598-020-70454-8","article-title":"Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status","volume":"10","author":"Lax","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"152310","DOI":"10.1016\/j.tox.2019.152310","article-title":"Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats","volume":"428","author":"Awwad","year":"2019","journal-title":"Toxicology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10557-020-07088-5","article-title":"Glucagon-Like Peptide-1 Analog Liraglutide Attenuates Pressure-Overload Induced Cardiac Hypertrophy and Apoptosis through Activating ATP Sensitive Potassium Channels","volume":"35","author":"Bai","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/CIRCULATIONAHA.118.038891","article-title":"Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca2+ Handling After Pressure Overload","volume":"141","author":"Bartoli","year":"2020","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/CS20100527","article-title":"Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats","volume":"121","author":"Benes","year":"2011","journal-title":"Clin. Sci."},{"key":"ref_21","first-page":"275","article-title":"Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl\/Rapp rats","volume":"62","author":"Biala","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"H867","DOI":"10.1152\/ajpheart.00538.2019","article-title":"The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension","volume":"318","author":"Bryson","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/cvr\/cvy131","article-title":"Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2\/3 transactivation","volume":"114","author":"Ford","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e005565","DOI":"10.1161\/CIRCHEARTFAILURE.118.005565","article-title":"Sacubitril\/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts","volume":"12","author":"Burke","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e006277","DOI":"10.1161\/CIRCHEARTFAILURE.119.006277","article-title":"Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure","volume":"13","author":"Byrne","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2019.09.010","article-title":"Genetic ablation and pharmacological inhibition of immunosubunit \u03b25i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice","volume":"137","author":"Cao","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104781","DOI":"10.1016\/j.phrs.2020.104781","article-title":"Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium","volume":"157","author":"Cappetta","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1159\/000430310","article-title":"Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats","volume":"36","author":"Cezar","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.bjp.0706801","article-title":"Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats","volume":"148","author":"Chan","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1177\/15353702211035058","article-title":"Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction","volume":"246","author":"Chang","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.109.131243","article-title":"Effect of rosuvastatin on cardiac remodeling. function. and progression to heart failure in hypertensive heart with established left ventricular hypertrophy","volume":"54","author":"Chang","year":"2009","journal-title":"Hypertension"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5876841","DOI":"10.1155\/2021\/5876841","article-title":"SIRT5-Related Desuccinylation Modification Contributes to Quercetin-Induced Protection against Heart Failure and High-Glucose-Prompted Cardiomyocytes Injured through Regulation of Mitochondrial Quality Surveillance","volume":"2021","author":"Chang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.redox.2018.10.021","article-title":"Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload","volume":"20","author":"Chen","year":"2019","journal-title":"Redox Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1074248414537705","article-title":"Chronic treatment with qiliqiangxin ameliorates aortic endothelial cell dysfunction in diabetic rats","volume":"20","author":"Chen","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/jcmm.17138","article-title":"Thymoquinone ameliorates pressure overload-induced cardiac hypertrophy by activating the AMPK signalling pathway","volume":"26","author":"Chen","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/13880209.2022.2040543","article-title":"Paeonol attenuates heart failure induced by transverse aortic constriction via ERK1\/2 signalling","volume":"60","author":"Chen","year":"2022","journal-title":"Pharm. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Chen, Y., Wang, L., Huang, S., Ke, J., Wang, Q., Zhou, Z., and Chang, W. (2021). Lutein attenuates angiotensin II-induced cardiac remodeling by inhibiting AP-1\/IL-11 signaling. Redox. Biol., 44.","DOI":"10.1016\/j.redox.2021.102020"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"H1313","DOI":"10.1152\/ajpheart.00863.2015","article-title":"Inhibition of late Na+ current. a novel target to improve diastolic function and electrical abnormalities in Dahl salt-sensitive rats","volume":"310","author":"Chi","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Chinnakkannu, P., Reese, C., Gaspar, J.A., Panneerselvam, S., Pleasant-Jenkins, D., Mukherjee, R., Baicu, C., Tourkina, E., Hoffman, S., and Kuppuswamy, D. (2018). Suppression of angiotensin II-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0207844"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"H633","DOI":"10.1152\/ajpheart.01301.2007","article-title":"All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system","volume":"294","author":"Choudhary","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e005762","DOI":"10.1161\/CIRCHEARTFAILURE.118.005762","article-title":"Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction","volume":"12","author":"Davila","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2016.04.168","article-title":"Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction","volume":"217","author":"Cappetta","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cvr\/cvn310","article-title":"Fish oil. but not flaxseed oil. decreases inflammation and prevents pressure overload-induced cardiac dysfunction","volume":"81","author":"Duda","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1093\/cvr\/cvac098","article-title":"Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of HFpEF","volume":"118","author":"Dulce","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1111\/bph.13686","article-title":"Sitagliptin reduces inflammation. fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction","volume":"174","author":"Esposito","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Evaristi, M.F., Poirier, B., Ch\u00e9ned\u00e9, X., Lefebvre, A.M., Roccon, A., Gillot, F., Beesk\u00e9, S., Corbier, A., Pruniaux-Harnist, M.P., and Janiak, P. (2022). A G-protein-biased S1P1 agonist. SAR247799. improved LVH and diastolic function in a rat model of metabolic syndrome. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0257929"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"H1408","DOI":"10.1152\/ajpheart.00140.2005","article-title":"l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats","volume":"289","author":"Fenning","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7256862","DOI":"10.1155\/2020\/7256862","article-title":"LCZ696. an Angiotensin Receptor-Neprilysin inhibitor. Improves Cardiac Hypertrophy and Fibrosis and Cardiac Lymphatic Remodeling in Transverse Aortic Constriction Model Mice","volume":"2020","author":"Ge","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-017-0657-9","article-title":"Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus","volume":"17","author":"Gimenes","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2016.08.013","article-title":"Cardioprotective role of peroxisome proliferator-activated receptor-\u03b3 agonist. rosiglitazone in a unique murine model of diabetic cardiopathy","volume":"162","author":"Giri","year":"2016","journal-title":"Life Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"H1440","DOI":"10.1152\/ajpheart.00007.2013","article-title":"Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload","volume":"305","author":"Gladden","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1111\/jcmm.14366","article-title":"Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure","volume":"7","author":"Goltsman","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/eurjhf\/hfq101","article-title":"Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction","volume":"12","author":"Aragoncillo","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1113\/JP274030","article-title":"Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse","volume":"595","author":"Mateo","year":"2017","journal-title":"J. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11684-014-0378-3","article-title":"Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis through inhibition of transforming growth factor \u03b2-induced Smad signaling","volume":"8","author":"Gong","year":"2014","journal-title":"Front. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/bph.12346","article-title":"Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure","volume":"170","author":"Gong","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bcp.2018.08.045","article-title":"Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension","volume":"156","author":"Gonzalez","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/FJC.0000000000000366","article-title":"Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists Cause Differential Cardiac Gene Expression in Pressure Overload-induced Cardiac Hypertrophy","volume":"67","author":"Grune","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Guan, X., Guan, X., Lu, C., Shang, B., Zhao, Y., Meng, Y., and Zhang, Z. (2020). Nebivolol combined with tetrahydrobiopterin affects diastolic function in spontaneously hypertensive rats via the nitric oxide\/cyclic guanosine monophosphate signalling pathway. BMC Pharmacol. Toxicol., 21.","DOI":"10.1186\/s40360-020-00460-z"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-016-0489-z","article-title":"Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes","volume":"16","author":"Habibi","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvu223","article-title":"Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4","volume":"104","author":"Hamdani","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10557-017-6734-1","article-title":"Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes","volume":"31","author":"Hammoudi","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijmm.2021.5066","article-title":"EGCG prevents pressure overload-induced myocardial remodeling by downregulating overexpression of HDAC5 in mice","volume":"49","author":"Han","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.7150\/ijbs.3.385","article-title":"Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone","volume":"3","author":"Henderson","year":"2007","journal-title":"Int. J. Biol. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1250858","DOI":"10.1155\/2021\/1250858","article-title":"BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats","volume":"2021","author":"Horvath","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fphar.2019.00998","article-title":"Carvacrol Attenuates Diabetic Cardiomyopathy by Modulating the PI3K\/AKT\/GLUT4 Pathway in Diabetic Mice","volume":"10","author":"Hou","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.freeradbiomed.2010.08.032","article-title":"Insulin and resveratrol act synergistically preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin","volume":"49","author":"Huang","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Huang, S., Wang, W., Li, L., Wang, T., Zhao, Y., Lin, Y., Huang, W., Wang, Y., and Huang, Z. (2021). P2X7 Receptor Deficiency Ameliorates STZ-induced Cardiac Damage and Remodeling Through PKC\u03b2 and ERK. Front. Cell. Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.692028"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.7150\/ijbs.49520","article-title":"Regulation of energy metabolism by combination therapy attenuates cardiac metabolic remodeling in heart failure","volume":"16","author":"Huang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"153633","DOI":"10.1016\/j.phymed.2021.153633","article-title":"An herbal preparation ameliorates heart failure with preserved ejection fraction by alleviating microvascular endothelial inflammation and activating NO-cGMP-PKG pathway","volume":"91","author":"Huang","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"H1805","DOI":"10.1152\/ajpheart.00536.2018","article-title":"Chronic, low-dose TMAO treatment reduces diastolic dysfunction and heart fibrosis in hypertensive rats","volume":"315","author":"Huc","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6699054","DOI":"10.1155\/2021\/6699054","article-title":"Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6\/STAT3 Inhibition by Raloxifene","volume":"2021","author":"Huo","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jphs.2016.08.008","article-title":"Cardiac DPP-4 inhibition by saxagliptin ameliorates isoproterenol-induced myocardial remodeling and cardiac diastolic dysfunction in rats","volume":"132","author":"Ikeda","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/cvr\/cvab206","article-title":"Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodelling and heart failure","volume":"118","author":"Jackson","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2012.12.003","article-title":"Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties","volume":"56","author":"Jeong","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"eaao0144","DOI":"10.1126\/scitranslmed.aao0144","article-title":"Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism","volume":"10","author":"Jeong","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1080\/21655979.2022.2053813","article-title":"MCC950 ameliorates ventricular arrhythmia vulnerability induced by heart failure","volume":"13","author":"Jiang","year":"2022","journal-title":"Bioengineered."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Johnson, J.A., West, J., Maynard, K.B., and Hemnes, A.R. (2011). ACE2 improves right ventricular function in a pressure overload model. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020828"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db16-0733","article-title":"The Sodium-Glucose Cotransporter 2 inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model","volume":"66","author":"Joubert","year":"2017","journal-title":"Diabetes"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"H2138","DOI":"10.1152\/ajpheart.00852.2006","article-title":"Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol","volume":"292","author":"Juric","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1074248419829168","article-title":"Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and \u03b2-Blocker Therapies: Analysis of Hypertensive Rats with Heart Failure","volume":"24","author":"Kakehi","year":"2019","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/jpet.120.000140","article-title":"\u03b23-Adrenergic Receptor Agonist Prevents Diastolic Dysfunction in an Angiotensin II-Induced Cardiomyopathy Mouse Model","volume":"376","author":"Kamiya","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCHEARTFAILURE.109.903450","article-title":"Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt\/Pim-1-mediated survival pathway","volume":"3","author":"Katare","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Khong, F.L., Zhang, Y., Edgley, A.J., Qi, W., Connelly, K.A., Woodman, O.L., Krum, H., and Kelly, D.J. (2011). 3\u2032,4\u2032-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 rats. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022777"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/01.CIR.103.1.148","article-title":"Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure","volume":"103","author":"Kim","year":"2001","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1291\/hypres.27.771","article-title":"Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model","volume":"27","author":"Izumi","year":"2004","journal-title":"Hypertens. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e013702","DOI":"10.1161\/JAHA.119.013702","article-title":"Serelaxin Improves Regional Myocardial Function in Experimental Heart Failure: An In Vivo Cardiac Magnetic Resonance Study","volume":"9","author":"Lapinskas","year":"2020","journal-title":"J. Am. Heart. Assoc."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12933-019-0849-6","article-title":"The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats","volume":"18","author":"Lee","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/10742484211034253","article-title":"Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction","volume":"26","author":"Leite","year":"2021","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"152774","DOI":"10.1016\/j.phymed.2018.11.034","article-title":"Luteolin protects against diabetic cardiomyopathy by inhibiting NF-\u03baB-mediated inflammation and activating the Nrf2-mediated antioxidant responses","volume":"59","author":"Li","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e018298","DOI":"10.1161\/JAHA.120.018298","article-title":"Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"9467271","DOI":"10.1155\/2020\/9467271","article-title":"Xiao-Qing-Long-Tang Maintains Cardiac Function during Heart Failure with Reduced Ejection Fraction in Salt-Sensitive Rats by Regulating the Imbalance of Cardiac Sympathetic Innervation","volume":"2020","author":"Li","year":"2020","journal-title":"Evid.-Based Complement. Alternat. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-015-2520-1","article-title":"Oleanolic acid alleviated pressure overload-induced cardiac remodeling","volume":"409","author":"Liao","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1291\/hypres.31.335","article-title":"Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation","volume":"31","author":"Liao","year":"2008","journal-title":"Hypertens. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13105-010-0039-1","article-title":"Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan--a proteomic analysis","volume":"66","author":"Liu","year":"2010","journal-title":"J. Physiol. Biochem."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Liu, L., Zhao, W., Liu, J., Gan, Y., Liu, L., and Tian, J. (2018). Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0205123"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCHEARTFAILURE.112.000123","article-title":"A novel immunomodulatory, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin","volume":"6","author":"Liu","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jphs.2018.08.010","article-title":"Icariside II attenuates cardiac remodeling via AMPK\u03b12\/mTORC1 in vivo and in vitro","volume":"138","author":"Liu","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3906\/sag-1704-142","article-title":"Effects of valproic acid on sympathetic activity and left ventricularmyocardial remodelling in rats during pressure overload","volume":"47","author":"Liu","year":"2017","journal-title":"Turk. J. Med. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1742-7843.2009.00440.x","article-title":"Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat","volume":"105","author":"Loch","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Lou, T., Ma, J., Xie, Y., Yao, G., Fan, Y., Ma, S., and Zou, X. (2021). Nuanxin capsule enhances cardiac function by inhibiting oxidative stress-induced mitochondrial dependent apoptosis through AMPK\/JNK signaling pathway. Biomed. Pharmacother., 135.","DOI":"10.1016\/j.biopha.2020.111188"},{"key":"ref_102","first-page":"41","article-title":"Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl\/Rapp rats","volume":"60","author":"Louhelainen","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.bjp.0707157","article-title":"Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl\/Rapp rats","volume":"150","author":"Louhelainen","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCRESAHA.111.258251","article-title":"Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity","volume":"110","author":"Lovelock","year":"2012","journal-title":"Circ. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-2840-12-28","article-title":"Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment","volume":"12","author":"Lu","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/FJC.0000000000000312","article-title":"Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis","volume":"67","author":"Luk","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"5546867","DOI":"10.1155\/2021\/5546867","article-title":"Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy","volume":"2021","author":"Ma","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Ma, X.L., Lin, Q.Y., Wang, L., Xie, X., Zhang, Y.L., and Li, H.H. (2019). Rituximab prevents and reverses cardiac remodeling by depressing B cell function in mice. Biomed. Pharmacother., 114.","DOI":"10.1016\/j.biopha.2019.108804"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbrc.2015.09.050","article-title":"AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress","volume":"474","author":"Ma","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"12331","DOI":"10.1111\/jcmm.15699","article-title":"Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes","volume":"24","author":"Madonna","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ejhf.711","article-title":"Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes","volume":"19","author":"Ruppert","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"14886","DOI":"10.1038\/s41598-021-94169-6","article-title":"Inhibition of the canonical Wnt signaling pathway by a \u03b2-catenin\/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis","volume":"11","author":"Methatham","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e006609","DOI":"10.1161\/CIRCHEARTFAILURE.119.006609","article-title":"Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction","volume":"13","author":"Methawasin","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.RES.0000200181.59551.71","article-title":"Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy","volume":"98","author":"Minhas","year":"2006","journal-title":"Circ. Res."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Mishra, M., Muthuramu, I., Aboumsallem, J.P., Kempen, H., and De Geest, B. (2018). Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113399"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41598-020-65255-y","article-title":"Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling cardiac dysfunction and heart failure in a murine model of HFpEF associated with hypertension","volume":"10","author":"Mishra","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FJC.0b013e31827fe59c","article-title":"Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction after aortic constriction in rats and mice","volume":"61","author":"Morgan","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1097\/HJH.0b013e328364abd6","article-title":"Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure","volume":"31","author":"Aragoncillo","year":"2013","journal-title":"J. Hypertens."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/cvr\/cvz002","article-title":"The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling","volume":"115","author":"Naruse","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12265-018-9795-z","article-title":"GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction","volume":"11","author":"Nguyen","year":"2018","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"11587","DOI":"10.1002\/jcp.27791","article-title":"Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling","volume":"234","author":"Nie","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ehf2.13177","article-title":"Sacubitril\/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload","volume":"8","author":"Bendiksen","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"R946","DOI":"10.1152\/ajpregu.00402.2006","article-title":"Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker","volume":"292","author":"Ohtani","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1124\/jpet.117.244459","article-title":"Sustained Activation of Guanylate Cyclase-A with TDT a Natriuretic Peptide Derivative Exhibits Cardiorenal Protection in Dahl Salt-Sensitive Hypertensive Rats","volume":"363","author":"Oishi","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1476-511X-9-95","article-title":"\u03c9-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin","volume":"9","author":"Chess","year":"2010","journal-title":"Lipids Health Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12933-020-00997-7","article-title":"Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat","volume":"19","author":"Park","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.HYP.0000226859.42064.ea","article-title":"Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy\/failure","volume":"48","author":"Perlini","year":"2006","journal-title":"Hypertension"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00125-014-3201-4","article-title":"Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db\/db mice","volume":"57","author":"Plante","year":"2014","journal-title":"Diabetologia"},{"key":"ref_129","first-page":"103321","article-title":"Pectins from various sources inhibit galectin-3-related cardiac fibrosis","volume":"70","author":"Meijers","year":"2022","journal-title":"Curr. Res. Transl. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/ejhf.1619","article-title":"Long-term effects of Na+\/Ca2+ exchanger inhibition with ORM-11035 improves cardiac function and remodelling without lowering blood pressure in a model of heart failure with preserved ejection fraction","volume":"21","author":"Primessnig","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1111\/j.1582-4934.2012.01632.x","article-title":"Rosuvastatin-attenuated heart failure in aged spontaneously hypertensive rats via PKC\u03b1\/\u03b22 signal pathway","volume":"16","author":"Qiu","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ajh\/hpw001","article-title":"Cardiac Protective Effects of Moringa oleifera Seeds in Spontaneous Hypertensive Rats","volume":"29","author":"Randriamboavonjy","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yjmcc.2018.08.017","article-title":"Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice","volume":"123","author":"Reddy","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e007300","DOI":"10.1161\/CIRCHEARTFAILURE.120.007300","article-title":"CRD-733, a Novel PDE9 (Phosphodiesterase 9) inhibitor, Reverses Pressure Overload-Induced Heart Failure","volume":"14","author":"Richards","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Rimbaud, S., Ruiz, M., Piquereau, J., Mateo, P., Fortin, D., Veksler, V., Garnier, A., and Ventura-Clapier, R. (2011). Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026391"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1074248420979235","article-title":"Repurposing From Oncology to Cardiology: Low-Dose 5-Azacytidine Attenuates Pathological Cardiac Remodeling in Response to Pressure Overload Injury","volume":"26","author":"Neary","year":"2021","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/FJC.0000000000000561","article-title":"Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction","volume":"71","author":"Salah","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-2828(02)00278-X","article-title":"Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure","volume":"35","author":"Satoh","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1253\/circj.67.705","article-title":"Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat","volume":"67","author":"Satoh","year":"2003","journal-title":"Circ. J."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Schauer, A., Adams, V., Augstein, A., Jannasch, A., Draskowski, R., Kirchhoff, V., Goto, K., Mittag, J., Galli, R., and M\u00e4nnel, A. (2021). Sacubitril\/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEF. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073570"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/gerona\/63.10.1034","article-title":"Chronic intake of a phytochemical-enriched diet reduces cardiac fibrosis and diastolic dysfunction caused by prolonged salt-sensitive hypertension","volume":"63","author":"Seymour","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.freeradbiomed.2019.06.029","article-title":"Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling","volume":"141","author":"Shang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1257283","DOI":"10.1155\/2021\/1257283","article-title":"Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a","volume":"2021","author":"Shao","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"F148","DOI":"10.1152\/ajprenal.00247.2019","article-title":"Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failure","volume":"318","author":"Shea","year":"2020","journal-title":"Am. J. Physiol.-Renal Physiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12933-019-0966-2","article-title":"GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy","volume":"18","author":"Shiraki","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Signore, P.E., Guo, G., Wei, Z., Zhang, W., Lin, A., and Del Balzo, U. (2021). A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0255022"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Stolina, M., Luo, X., Dwyer, D., Han, C.Y., Chen, R., Zhang, Y., Xiong, Y., Chen, Y., Yin, J., and Shkumatov, A. (2020). The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15. PLoS ONE, 15.","DOI":"10.1101\/2020.03.20.000307"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-020-01000-z","article-title":"Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet","volume":"19","author":"Sukumaran","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/ehf2.13013","article-title":"Reverse electromechanical modelling of diastolic dysfunction in spontaneous hypertensive rat after sacubitril\/valsartan therapy","volume":"7","author":"Sung","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1111\/bph.15048","article-title":"Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure","volume":"177","author":"Tamayo","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","article-title":"SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy","volume":"136","author":"Tang","year":"2017","journal-title":"Circulation"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ajh.2009.228","article-title":"Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure","volume":"23","author":"Thandapilly","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"H2118","DOI":"10.1152\/ajpheart.01000.2004","article-title":"Thyroid hormones induce unique and potentially beneficial changes in cardiac myocyte shape in hypertensive rats near heart failure","volume":"288","author":"Thomas","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1161\/CIRCULATIONAHA.120.046462","article-title":"HDAC Inhibition Reverses Preexisting Diastolic Dysfunction and Blocks Covert Extracellular Matrix Remodeling","volume":"143","author":"Travers","year":"2021","journal-title":"Circulation"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e003381","DOI":"10.1161\/CIRCHEARTFAILURE.116.003381","article-title":"Dual Endothelin-A\/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction","volume":"9","author":"Li","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Venardos, K., De Jong, K.A., Elkamie, M., Connor, T., and McGee, S.L. (2015). The PKD inhibitor CID755673 enhances cardiac function in diabetic db\/db mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120934"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1038\/s41598-017-09470-0","article-title":"Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3197320","DOI":"10.1155\/2017\/3197320","article-title":"Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats","volume":"2017","author":"Wang","year":"2017","journal-title":"Evid.-Based Complement. Alternat. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/ATVBAHA.119.313883","article-title":"Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction","volume":"40","author":"Wang","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jsbmb.2017.02.007","article-title":"1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the \u03b2-catenin\/TCF4\/GSK-3\u03b2\/mTOR pathway","volume":"168","author":"Wei","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00395-012-0308-y","article-title":"Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo","volume":"107","author":"Westermann","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00395-009-0014-6","article-title":"Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure","volume":"104","author":"Westermann","year":"2009","journal-title":"Basic Res. Cardiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/db06-1163","article-title":"Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: The role of angiotensin type 1 receptor antagonism","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e96006","DOI":"10.1172\/jci.insight.96006","article-title":"Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction","volume":"3","author":"Wilck","year":"2018","journal-title":"JCI Insight"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"H867","DOI":"10.1152\/ajpheart.00704.2013","article-title":"Ranolazine improves diastolic function in spontaneously hypertensive rats","volume":"306","author":"Williams","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Wu, B., Lin, J., Luo, J., Han, D., Fan, M., Guo, T., Tao, L., Yuan, M., and Yi, F. (2017). Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/3764370"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.carpath.2015.04.008","article-title":"Treatment with hydrogen molecule attenuates cardiac dysfunction in streptozotocin-induced diabetic mice","volume":"24","author":"Wu","year":"2015","journal-title":"Cardiovasc. Pathol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lfs.2015.12.034","article-title":"Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1\/p38 signaling in mice","volume":"145","author":"Wu","year":"2016","journal-title":"Life Sci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"698056","DOI":"10.3389\/fcvm.2021.698056","article-title":"Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPAR\u03b3","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.3892\/mmr.2017.7288","article-title":"Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin\/NFAT2 pathway","volume":"16","author":"Xiao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1002\/jcb.26041","article-title":"Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy","volume":"118","author":"Xiao","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Xu, C.N., Kong, L.H., Ding, P., Liu, Y., Fan, Z.G., Gao, E.H., Yang, J., and Yang, L.F. (2020). Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt\/mTOR pathway. Biochim. Biophys. Acta Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165848"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cardfail.2008.06.006","article-title":"Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice","volume":"14","author":"Xu","year":"2008","journal-title":"J. Card. Fail."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3892\/mmr.2013.1548","article-title":"Rosuvastatin prevents pressure overload-induced myocardial hypertrophy via inactivation of the Akt, ERK1\/2 and GATA4 signaling pathways in rats","volume":"8","author":"Xu","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/15257771003738683","article-title":"Delayed treatment effects of xanthine oxidase inhibition on systolic overload-induced left ventricular hypertrophy and dysfunction","volume":"29","author":"Xu","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1042\/CS20190585","article-title":"Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice","volume":"133","author":"Xue","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cardfail.2017.09.001","article-title":"Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats","volume":"24","author":"Yamamoto","year":"2018","journal-title":"J. Card. Fail."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"5270508","DOI":"10.1155\/2020\/5270508","article-title":"Crude Radix Aconiti Lateralis Preparata (Fuzi) with Glycyrrhiza Reduces Inflammation and Ventricular Remodeling in Mice through the TLR4\/NF-\u03baB Pathway","volume":"2020","author":"Yan","year":"2020","journal-title":"Mediators Inflamm."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e1800807","DOI":"10.1002\/mnfr.201800807","article-title":"Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure","volume":"63","author":"Yan","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_182","first-page":"14345","article-title":"Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCHEARTFAILURE.110.957050","article-title":"Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure","volume":"4","author":"Yin","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/bph.13479","article-title":"Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats","volume":"173","author":"Youcef","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Yu, J., Chen, R., Tan, Y., Wu, J., Qi, J., Zhang, M., and Gu, W. (2016). Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1\/2\/GATA4 Signaling Pathway after Pressure Overload in Mice. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166560"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2147\/DDDT.S111253","article-title":"Chloroquine improves left ventricle diastolic function in streptozotocin-induced diabetic mice","volume":"10","author":"Yuan","year":"2016","journal-title":"Drug. Des. Devel. Ther."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jjcc.2013.06.008","article-title":"Puerarin attenuates pressure overload-induced cardiac hypertrophy","volume":"63","author":"Yuan","year":"2014","journal-title":"J. Cardiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3389\/fphar.2018.01227","article-title":"Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor \u03b1 and Its Downstream Signaling","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11010-016-2716-z","article-title":"Nobiletin attenuates cardiac dysfunction, oxidative stress and inflammatory in streptozotocin: Induced diabetic cardiomyopathy","volume":"417","author":"Zhang","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.2147\/DDDT.S144807","article-title":"Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor","volume":"11","author":"Zhang","year":"2017","journal-title":"Drug. Des. Devel. Ther."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/eurjhf\/hfs011","article-title":"FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy","volume":"14","author":"Zhang","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-021-01312-8","article-title":"Dapagliflozin: A sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGF\u03b21\/Smad signaling","volume":"20","author":"Zhang","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1291\/hypres.31.1977","article-title":"Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress","volume":"31","author":"Zhao","year":"2008","journal-title":"Hypertens. Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"108046","DOI":"10.1016\/j.intimp.2021.108046","article-title":"Selective Inhibition of NLRP3 Inflammasome Reverses Pressure Overload-Induced Pathological Cardiac Remodeling by Attenuating Hypertrophy, Fibrosis and Inflammation","volume":"99","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/abbs\/gmy177","article-title":"Liraglutide alleviates cardiac fibrosis through inhibiting P4h\u03b1-1 expression in STZ-induced diabetic cardiomyopathy","volume":"51","author":"Zhao","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_196","first-page":"6227330","article-title":"Hdac8 inhibitor Alleviates Transverse Aortic Constriction-Induced Heart Failure in Mice by Downregulating Ace1","volume":"2022","author":"Zhao","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1038\/s41598-018-27064-2","article-title":"An essential role for Wnt\/\u03b2-catenin signaling in mediating hypertensive heart disease","volume":"8","author":"Zhao","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_198","first-page":"e923025","article-title":"Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway","volume":"26","author":"Zhao","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcp.2015.03.009","article-title":"Treatment with angiotensin-(1-9) alleviates the cardiomyopathy in streptozotocin-induced diabetic rats","volume":"95","author":"Zheng","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S213910","article-title":"Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats","volume":"13","author":"Zheng","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Zhou, G.F., Jiang, Y.H., Ma, D.F., Wang, Y.C., Yang, J.L., Chen, J.Y., Chi, C.Y., Han, X.W., Li, Z.Y., and Li, X. (2019). Xiao-Qing-Long Tang Prevents Cardiomyocyte Hypertrophy, Fibrosis and the Development of Heart Failure with Preserved Ejection Faction in Rats by Modulating the Composition of the Gut Microbiota. BioMed Res. Int., 2019.","DOI":"10.1155\/2019\/9637479"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/jcp.27070","article-title":"Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabrfoisadine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy","volume":"234","author":"Zuo","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Hooijmans, C.R., Rovers, M.M., de Vries, R.B., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE\u2019s risk of bias tool for animal studies. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-43"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ejhf.1673","article-title":"European Society of Cardiology\/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure","volume":"22","author":"Coats","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1081\/JDI-100100882","article-title":"Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats","volume":"22","author":"Tofovic","year":"2000","journal-title":"Ren. Fail."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.115.305250","article-title":"The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms","volume":"118","author":"Roh","year":"2016","journal-title":"Circ. Res."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Jasi\u0144ska-Stroschein, M. (2022). Training programs in preclinical studies. The example of pulmonary hypertension. Systematic review and meta-analysis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0276875"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/eurheartj\/ehaa587","article-title":"Assessing left ventricular systolic function: From ejection fraction to strain analysis","volume":"42","author":"Halliday","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIRCRESAHA.116.310119","article-title":"Why Don\u2019t We Have Proven Treatments for HFpEF?","volume":"120","author":"Roh","year":"2017","journal-title":"Circ. Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1093\/cvr\/cvab009","article-title":"Reciprocal organ interactions during heart failure: A position paper from the ESC Working Group on Myocardial Function","volume":"117","author":"Ciccarelli","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1093\/eurheartj\/ehab389","article-title":"Heart failure with preserved ejection fraction in humans and mice: Embracing clinical complexity in mouse models","volume":"42","author":"Withaar","year":"2021","journal-title":"Eur. Heart J."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/10\/1449\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:05:42Z","timestamp":1760130342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/10\/1449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":211,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ph16101449"],"URL":"https:\/\/doi.org\/10.3390\/ph16101449","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]}}}